icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
Back grey_arrow_rt.gif
 
 
 
GS-2829 and GS-6779 HBV therapeutic vaccine generates robust, polyfunctional, genotype cross-reactive CD8 T cell responses accompanied by high titers of anti-HBsAg antibodiess
 
 
  AASLD 2022 Nov 4-8

1111221

1111222

1111223

1111224

1111225

1111226

1111227